| 摘要 |
Inhibitors of tissue transglutaminase (ttgase) find use in the treatment of angiogenesis in a subject. In particular, the ttgase inhibitor compounds are those of Formula (I), wherein R1, R2 and X are as defined therein. The said compound are of use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD).
|
